Complying with the European Clinical Trials directive while surviving the administrative pressure – An alternative approach to toxicity registration in a cancer trial-Reference-Cited by-同舟云学术

Complying with the European Clinical Trials directive while surviving the administrative pressure – An alternative approach to toxicity registration in a cancer trial

Published:2014-01 Issue:2 Volume:50 Page:251-259
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Frandsen Thomas Leth,Heyman Mats,Abrahamsson Jonas,Vettenranta Kim,Åsberg Ann,Vaitkeviciene Goda,Pruunsild Kaie,Toft Nina,Birgens Henrik,Hallböök Helena,Quist-Paulsen Petter,Griškevičius Laimonas,Helt Louise,Hansen Birgitte Vilsbøll,Schmiegelow Kjeld

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Effect of European clinical trials directive on academic drug trials in Denmark: retrospective study of applications to the Danish medicines agency 1993–2006;Berendt;BMJ,2008

2. Clinical trials directive slows registration of paediatric studies;Cannell;Lancet Oncol,2007

3. The European clinical trials directive and its impact on critical care and emergency research;Robinson;Curr Opin Crit Care,2011

4. The impact of the ‘clinical trials’ directive on the cost and conduct of non-commercial cancer trials in the UK;Hearn;Eur J Cancer,2007

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parents' perception of treatment‐related toxicity in children treated according to the NOPHO ALL2008 protocol for acute lymphoblastic leukemia;HemaSphere;2024-07

3. Chemotherapy‐related toxicities follow a typical pattern in children treated for acute lymphoblastic leukaemia;Acta Paediatrica;2024-01-04

4. Hyperlipidemia in children and adolescents with acute lymphoblastic leukemia: A systematic review and meta‐analysis;Pediatric Blood & Cancer;2023-09-30

5. Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia;Acta Oncologica;2023-09-19